Stereochemistry | RACEMIC |
Molecular Formula | C19H24N2S.C14H10O4 |
Molecular Weight | 554.699 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
Stereo Comments | C19H24N2S |
SHOW SMILES / InChI
SMILES
OC(=O)C1=C(C=CC=C1)C(=O)C2=CC=C(O)C=C2.CCN(CC)C(C)CN3C4=CC=CC=C4SC5=CC=CC=C35
InChI
InChIKey=MJRQYMOUGYDNHE-UHFFFAOYSA-N
InChI=1S/C19H24N2S.C14H10O4/c1-4-20(5-2)15(3)14-21-16-10-6-8-12-18(16)22-19-13-9-7-11-17(19)21;15-10-7-5-9(6-8-10)13(16)11-3-1-2-4-12(11)14(17)18/h6-13,15H,4-5,14H2,1-3H3;1-8,15H,(H,17,18)
Molecular Formula | C14H10O4 |
Molecular Weight | 242.2268 |
Charge | 0 |
Count |
MOL RATIO
1 MOL RATIO (average) |
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C19H24N2S |
Molecular Weight | 312.472 |
Charge | 0 |
Count |
MOL RATIO
1 MOL RATIO (average) |
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Ethopropazine is an anticholinergic drug. Ethopropazine is an inhibitor of butyrylcholinesterase and non-selective muscarinic acetylcholine receptor antagonist. Ethopropazine has been used for the treatment of parkinsonism and drug-induced extrapyramidal reactions. Also It used for the symptomatic treatment of hepatolenticular degeneration and congenital athetosis.
CNS Activity
Originator
Approval Year
Overview
CYP3A4 | CYP2C9 | CYP2D6 | hERG |
---|---|---|---|
OverviewOther
Other Inhibitor | Other Substrate | Other Inducer |
---|---|---|
Tox targets
Sourcing
PubMed
Patents
Sample Use Guides
ETHOPROPAZINE HYDROCHLORIDE TABLETS USP
Usual adult and adolescent dose
Parkinsonism and Drug-induced extrapyramidal reactions
Oral, 50 mg one or two times a day, the dosage being increased as needed and tolerated. In severe cases, the dose may be increased gradually to a total of 500 to 600 mg a day.
Route of Administration:
Oral